# 以岭药业 — WebsDocs ASG Directory Profile This is a public business listing published by the WebsDocs ASG Directory. It provides machine-readable public information and static answers. It is not a live seller AI. Canonical Directory profile: https://directory.websdocs.com/business/yiling-cn Canonical Directory JSON: https://directory.websdocs.com/business/yiling-cn.json Machine-readable public profile: https://aig.websdocs.com/ai/yiling-cn/profile Company profile JSON: https://aig.websdocs.com/ai/yiling-cn/data/aig-company-profile.json Static Agent Card: https://aig.websdocs.com/ai/yiling-cn/.well-known/agent-card.json Public discovery endpoints: - Profile: https://aig.websdocs.com/ai/yiling-cn/profile - Company JSON: https://aig.websdocs.com/ai/yiling-cn/data/aig-company-profile.json - Services: https://aig.websdocs.com/ai/yiling-cn/services - Offers: https://aig.websdocs.com/ai/yiling-cn/offers - Schema: https://aig.websdocs.com/ai/yiling-cn/schema.jsonld - Agent Card: https://aig.websdocs.com/ai/yiling-cn/.well-known/agent-card.json Business summary: 以岭药业 以岭药业(002603) 22.84 0.89(4.05%) 采购平台 企业 OA 企业邮箱 CHN ENG 以岭药业(002603) 首页 关于以岭 以岭概况 创始人介绍 董事长介绍 荣誉殿堂 企业文化 以岭动态 公司要闻 视频中心 以岭公益 产品展示 创新中药 化药系列 健康产品 配方颗粒 投资者关系 基本概况 公司公告 年度报告 社会责任报告 加入我们 人才理念 校园招聘 社会招聘 联系我们 联系我们 安全性信息反馈 采购平台 企业 OA 企业邮箱 EHR CHN ENG "> --> SCIENCE AND TECHNOLOGY HEALTH TOMORROW 传承创新 中医药引领者 了解更多 "> --> SCIENCE AND TECHNOLOGY HEALTH TOMORROW 创新中药 守护国人健康 了解更多 "> --> SCIENCE AND TECHNOLOGY HEALTH TOMORROW 民族医药 全球共享惠及世界 了解更多 以岭动态 News 查看更多动态 以岭药业三款通络药临床研究入选“2026年国际中医药与传统医药高影响力研究” 近日，第二届亚太传统药物质量大会暨2026国际中医药与传统医药研讨会上发布了“2026年国际中医药与传统医药高影响力研究”。以岭药业三款通络药物，参松养心、芪苈强心、津力达开展的3项国际标准高质量循证医学研究成果——“参松养心胶囊对持续性心... Status and boundaries: - Directory public profile - Customer-owned domain required: not applicable - Active seller agent: false - A2A messaging: unavailable - Live reasoning or RAG: unavailable - UCP and MCP: unavailable - Checkout and payment execution: unavailable - Private data access: unavailable Use the canonical Directory profile for current public evidence. Do not infer that a live AI Sales Gateway is active.